Jamadermatology Adotama 201

Total Page:16

File Type:pdf, Size:1020Kb

Jamadermatology Adotama 201 Letters Barber Knowledge and Recommendations Figure. Comparison of Barber Recommendations Regarding Home Care Regarding Pseudofolliculitis Barbae for Clients With Pseudofolliculitis Barbae (PFB) and Acne Keloidalis Nuchae in an Urban Setting and Acne Keloidalis Nuchae (AKN) Pseudofolliculitis barbae (PFB) and acne keloidalis nuchae 30 (AKN) are chronic inflammatory conditions affecting hair fol- Skin diagnosis licles common in men of color who are genetically inclined to AKN 1 25 have tightly curled hair. The incidence of PFB and AKN PFB among African American men may be as high as 83.0% and 20 13.6%, respectively.2,3 The barbershop represents a distinctly important institu- 15 tion in the African American community and constitutes a cul- turally appropriate venue for barbers to provide men with Barbers, No. 10 health information.4 The knowledge and expertise afforded by barbers regard- 5 ing dermatologic evaluation and intervention of common scalp and hair problems in this population has not been evaluated. 0 The aim of this cross-sectional study was to assess barber per- Use Chemical Do Not Shave Using Shave Using Depilatories Shave Clippers Razors ceptions and recommendations regarding PFB and AKN in pre- Barber Recommendations Regarding Home Care dominantly African American barbershops. Methods | This cross-sectional study was approved by the in- knew that razor use would worsen AKN, their ideas on how to stitutional review board at the University of Oklahoma Health address these conditions differed widely (Figure). Avoiding Sciences Center, Oklahoma City. We collected a list of barber- shaving completely is a valid consideration and arguably the shops in the greater Oklahoma City area servicing predomi- most effective way to treat both conditions; however, this ap- nantly African American clientele. No more than 2 barbers were proach severely limits styling and grooming practice options selected at each shop. Each barber provided verbal consent and for a client. Dermatologists have an opportunity to educate bar- participated in a 20-question survey. Each barber was then bers about various treatment options available, such as chemi- given an educational pamphlet on PFB and AKN. The pam- cal depilatories, clippers use, or referral to a dermatologist for phlet showed digital images of these skin conditions and ex- topical or oral prescription medications or laser hair removal. plained how to manage them or when to refer to a dermatolo- A 2014 review of barber-administered health education gist. All the data was collected using REDCAP (Research programs in African American communities showed that edu- Electronic Data Capture). cational training promotes positive health behaviors among customers.4 Barbers represent a unique resource to commu- Results | Fifty barbers from 37 barbershops in greater Okla- nicate medical information to clients. This opens a potential homa City were enrolled from April through May, 2017. Of collaborative opportunity among barbers, clients, and health these, 39 barbers (78%) properly identified PFB while only 22 care professionals. (44%) were able to identify AKN from a photograph. Eight bar- Limitations of this study include recall bias and general- bers (16%) confused PFB with tinea barbae, a fungal infection izability because of data collection in a single city. limited to the bearded region, and 15 (30%) confused AKN with Barbers can identify PFB and, in fewer clients, AKN, and tinea barbae. often advise them how to care for these medical conditions. Twenty-nine barbers (58%) indicated that they avoid cut- The dermatologic community can offer appropriate guidance ting the hair of clients who have PFB and 23 (46%) avoid cut- so that barbers can become a unique ally in recognizing and ting hair of clients who have AKN. Among the respondents, 47 treating PFB and AKN. (94%) knew that razor use would aggravate AKN and 49 (98%) knew it would aggravate PFB. Nineteen barbers (38%) ad- Prince Adotama, MD vised clients with PFB and 26 (52%) counseled clients with AKN Daniel Tinker, BS to never shave at home. Twenty-two barbers (44%) coun- Krystal Mitchell, MBA seled clients to shave with clippers at home for PFB and 14 Donald A. Glass II, MD, PhD (28%) for AKN (Figure). Recommendation to use chemical de- Pamela Allen, MD pilatories was not favored. Author Affiliations: Department of Dermatology, University of Oklahoma Discussion | The majority of the barbers identified PFB. It was Health Science Center, Oklahoma City (Adotama, Allen); Medical student, more difficult to identify AKN, with only 44% of participants University of Oklahoma College of Medicine, Oklahoma City (Tinker, Mitchell); Department of Dermatology, University of Texas Southwestern Medical Center, recognizing this condition. Tinea barbae was a competing di- Dallas (Glass). agnosis for PFB (16%) and, more commonly, for AKN (30%). Corresponding Author: Pamela Allen, MD, Department of Dermatology, This suggests that more education for barbers regarding diag- University of Oklahoma Health Science Center, 619 NE 13th St, Oklahoma City, nosis and treatment of fungal infections is necessary. While OK 73104 ([email protected]). 94% of barbers knew that razor use would worsen PFB and 98% Accepted for Publication: July 30, 2017. jamadermatology.com (Reprinted) JAMA Dermatology December 2017 Volume 153, Number 12 1325 © 2017 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/26/2021 Letters Published Online: October 18, 2017. doi:10.1001/jamadermatol.2017.3668 infection involves the nail matrix, systemic therapy is often Author Contributions: Dr Adotama and Mr Tinker had full access to all of the indicated.2 Terbinafine is the systemic antifungal of choice, data in the study and take responsibility for the integrity of the data and the with cure rates as high as 80%.3 Though terbinafine is well tol- accuracy of the data analysis. erated, hepatotoxic effects have been reported in adults.4 There Study concept and design: Adotama, Glass, Allen. Acquisition, analysis, or interpretation of data: Adotama, Tinker, Mitchell. are fewer risk factors for liver injury in children and consen- Drafting of the manuscript: Adotama, Tinker, Mitchell. sus regarding laboratory surveillance during therapy has not Critical revision of the manuscript for important intellectual content: All authors. been reached, with physician preference varying widely. The Statistical analysis: Adotama, Tinker, Mitchell. Administrative, technical, or material support: Adotama, Tinker, Mitchell. aim of our study was to investigate the prevalence of labora- Study supervision: Adotama, Tinker, Allen. tory monitoring and laboratory abnormalities during sys- Conflict of Interest Disclosures: None reported. temic terbinafine therapy in pediatric patients with onycho- 1. Alexis A, Heath CR, Halder RM. Folliculitis keloidalis nuchae and mycosis. pseudofolliculitis barbae: are prevention and effective treatment within reach? Dermatol Clin. 2014;32(2):183-191. Methods | We conducted an institutional review board- 2. Perry PK, Cook-Bolden FE, Rahman Z, Jones E, Taylor SC. Defining approved retrospective medical record review of patients seen pseudofolliculitis barbae in 2001: a review of the literature and current trends. J Am Acad Dermatol. 2002;46(2)(Suppl Understanding):S113-S119. at Children’s Hospital of Philadelphia for onychomycosis from 3. Olsen EA, Bergfeld WF, Cotsarelis G, et al; Workshop on Cicatricial Alopecia. December 2008 to December 2016. Patients not prescribed sys- Summary of North American Hair Research Society (NAHRS)–sponsored temic terbinafine therapy were excluded. Laboratory abnor- workshop on cicatricial alopecia, Duke University Medical Center, February 10 malities were graded based on The National Cancer Institute and 11, 2001. J Am Acad Dermatol. 2003;48(1):103-110. Common Terminology Criteria for Adverse Events (version 4. Luque JS, Ross L, Gwede CK. Qualitative systematic review of 4.03).5 Statistical analyses were performed using Stata statis- barber-administered health education, promotion, screening and outreach programs in African-American communities. J Community Health. 2014;39(1): tical software (version 14.2, Stata Corp). 181-190. Results | Over an 8-year period, 1302 patients were diagnosed Laboratory Monitoring During Systemic Terbinafine with onychomycosis. Of these, 269 (21%) were prescribed oral Therapy for Pediatric Onychomycosis terbinafine and were included in analysis (Table 1 and Table 2). Onychomycosis is a fungal infection of the nail resulting in dis- A total of 192 (71.4%) patients were treated by pediatricians and coloration, thickening, and separation from the nail bed. Pe- 77 (28.6%) were treated by pediatric dermatologists. Mean (SD) diatric onychomycosis has a reported incidence of 0.4% to age at initial presentation was 11.5 (3.9) years (range, 2-20 years). 2.6%.1 Topical antifungal therapy has been shown to have some The male to female ratio of the study population was 1.5:1.0, efficacy in children compared with adults; however, when the with 160 (59%) male patients and 109 (41%) female. Diagnosis of onychomycosis was confirmed by nail cul- ture and/or periodic–acid schiff (PAS) stain in 128 (48%) cases Table 1. Demographics of the Study Population and Patients Who Underwent Laboratory Monitoring prior to initiation of treatment. Seventy-two (56%) patients had positive culture results, 44 (34%) patients had positive PAS stain Overall Demographics of Study Population Finding results,
Recommended publications
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Pediatric and Adolescent Dermatology
    Pediatric and adolescent dermatology Management and referral guidelines ICD-10 guide • Acne: L70.0 acne vulgaris; L70.1 acne conglobata; • Molluscum contagiosum: B08.1 L70.4 infantile acne; L70.5 acne excoriae; L70.8 • Nevi (moles): Start with D22 and rest depends other acne; or L70.9 acne unspecified on site • Alopecia areata: L63 alopecia; L63.0 alopecia • Onychomycosis (nail fungus): B35.1 (capitis) totalis; L63.1 alopecia universalis; L63.8 other alopecia areata; or L63.9 alopecia areata • Psoriasis: L40.0 plaque; L40.1 generalized unspecified pustular psoriasis; L40.3 palmoplantar pustulosis; L40.4 guttate; L40.54 psoriatic juvenile • Atopic dermatitis (eczema): L20.82 flexural; arthropathy; L40.8 other psoriasis; or L40.9 L20.83 infantile; L20.89 other atopic dermatitis; or psoriasis unspecified L20.9 atopic dermatitis unspecified • Scabies: B86 • Hemangioma of infancy: D18 hemangioma and lymphangioma any site; D18.0 hemangioma; • Seborrheic dermatitis: L21.0 capitis; L21.1 infantile; D18.00 hemangioma unspecified site; D18.01 L21.8 other seborrheic dermatitis; or L21.9 hemangioma of skin and subcutaneous tissue; seborrheic dermatitis unspecified D18.02 hemangioma of intracranial structures; • Tinea capitis: B35.0 D18.03 hemangioma of intraabdominal structures; or D18.09 hemangioma of other sites • Tinea versicolor: B36.0 • Hyperhidrosis: R61 generalized hyperhidrosis; • Vitiligo: L80 L74.5 focal hyperhidrosis; L74.51 primary focal • Warts: B07.0 verruca plantaris; B07.8 verruca hyperhidrosis, rest depends on site; L74.52 vulgaris (common warts); B07.9 viral wart secondary focal hyperhidrosis unspecified; or A63.0 anogenital warts • Keratosis pilaris: L85.8 other specified epidermal thickening 1 Acne Treatment basics • Tretinoin 0.025% or 0.05% cream • Education: Medications often take weeks to work AND and the patient’s skin may get “worse” (dry and red) • Clindamycin-benzoyl peroxide 1%-5% gel in the before it gets better.
    [Show full text]
  • Isotretinoin Induced Periungal Pyogenic Granuloma Resolution with Combination Therapy Jonathan G
    Isotretinoin Induced Periungal Pyogenic Granuloma Resolution with Combination Therapy Jonathan G. Bellew, DO, PGY3; Chad Taylor, DO; Jaldeep Daulat, DO; Vernon T. Mackey, DO Advanced Desert Dermatology & Mohave Centers for Dermatology and Plastic Surgery, Peoria, AZ & Las Vegas, NV Abstract Management & Clinical Course Discussion Conclusion Pyogenic granulomas are vascular hyperplasias presenting At the time of the periungal eruption on the distal fingernails, Excess granulation tissue and pyogenic granulomas have It has been reported that the resolution of excess as red papules, polyps, or nodules on the gingiva, fingers, the patient was undergoing isotretinoin therapy for severe been described in both previous acne scars and periungal granulation tissue secondary to systemic retinoid therapy lips, face and tongue of children and young adults. Most nodulocystic acne with significant scarring. He was in his locations.4 Literature review illustrates rare reports of this occurs on withdrawal of isotretinoin.7 Unfortunately for our commonly they are associated with trauma, but systemic fifth month of isotretinoin therapy with a cumulative dose of adverse event. In addition, the mechanism by which patient, discontinuation of isotretinoin and prevention of retinoids have rarely been implicated as a causative factor 140 mg/kg. He began isotretinoin therapy at a dose of 40 retinoids cause excess granulation tissue of the skin is not secondary infection in areas of excess granulation tissue in their appearance. mg daily (0.52 mg/kg/day) for the first month and his dose well known. According to the available literature, a course was insufficient in resolving these lesions. To date, there is We present a case of eruptive pyogenic granulomas of the later increased to 80 mg daily (1.04 mg/kg/day).
    [Show full text]
  • Onychomycosis/ (Suspected) Fungal Nail and Skin Protocol
    Onychomycosis/ (suspected) Fungal Nail and Skin Protocol Please check the boxes of the evaluation questions, actions and dispensing items you wish to include in your customized protocol. If additional or alternative products or services are provided, please include when making your selections. If you wish to include the condition description please also check the box. Description of Condition: Onychomycosis is a common nail condition. It is a fungal infection of the nail that differs from bacterial infections (often referred to as paronychia infections). It is very common for a patient to present with onychomycosis without a true paronychia infection. It is also very common for a patient with a paronychia infection to have secondary onychomycosis. Factors that can cause onychomycosis include: (1) environment: dark, closed, and damp like the conventional shoe, (2) trauma: blunt or repetitive, (3) heredity, (4) compromised immune system, (5) carbohydrate-rich diet, (6) vitamin deficiency or thyroid issues, (7) poor circulation or PVD, (8) poor-fitting shoe gear, (9) pedicures received in places with unsanitary conditions. Nails that are acute or in the early stages of infection may simply have some white spots or a white linear line. Chronic nail conditions may appear thickened, discolored, brittle or hardened (to the point that the patient is unable to trim the nails on their own). The nails may be painful to touch or with closed shoe gear or the nail condition may be purely cosmetic and not painful at all. *Ask patient to remove nail
    [Show full text]
  • Fundamentals of Dermatology Describing Rashes and Lesions
    Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous,
    [Show full text]
  • Dermatologic Nuances in Children with Skin of Color
    5/21/2019 Dermatologic Nuances in Children with Skin of Color Candrice R. Heath, MD, FAAP, FAAD Director, Pediatric Dermatology LKSOM Temple University @DrCandriceHeath Advisory Board – Pfizer, Regeneron-Sanofi Consultant –Marketing – Unilever, Proctor & Gamble Speaker’s Bureau - Pfizer I do not intend to discuss on-FDA approved or investigational use of products in my presentation. • Recognize common hair, scalp and skin disorders that may present differently in children with skin of color • Select appropriate treatment options based upon common cultural preferences to increase adherence • Establish treatment algorithm for challenging cases 1 5/21/2019 • 2050 : Over half of the United States population will be people of color • 2050 : 1 in 3 US residents will be Hispanic • 2023 : Over half of the children in the US will be people of color • Focuses on ethnic and racial groups who have – similar skin characteristics – similar skin diseases – similar reaction patterns to those skin diseases Taylor SC et al. (2016) Defining Skin of Color. In Taylor & Kelly’s Dermatology for Skin of Color. 2016 Type I always burns, never tans (palest) Type II usually burns, tans minimally Type III sometimes mild burn, tans uniformly Type IV burns minimally, always tans well (moderate brown) Type V very rarely burns, tans very easily (dark brown) Type VI Never burns (deeply pigmented dark brown to darkest brown) 2 5/21/2019 • Black • Asian • Hispanic • Other Not so fast… • Darker skin hues • The term “race” is faulty – Race may not equal biological or genetic inheritance – There is not one gene or characteristic that separates every person of one race from another Taylor SC et al.
    [Show full text]
  • WHAT YOU NEED to KNOW ABOUT SEYSARA® a Novel Treatment Developed Specifi Cally for Acne
    Not an actual patient, results may vary. WHAT YOU NEED TO KNOW ABOUT SEYSARA® A novel treatment developed specifi cally for acne. PLEASE SEE THE ACCOMPANYING PATIENT INFORMATION AND FULL PRESCRIBING INFORMATION. almirall.us INTRODUCING SEYSARA: A NOVEL ORAL ANTIBIOTIC TREATMENT DESIGNED SPECIFICALLY FOR ACNE WHAT IS SEYSARA? WHAT CAUSES ACNE? SEYSARA is a prescription medicine used to treat moderate to Acne appears when a small hole in our skin (pore) clogs with dead severe acne vulgaris in people 9 years and older. SEYSARA should not skin cells. Normally, dead skin cells rise to the surface of the pore, be used for the treatment or prevention of infections. It is not known where they are shed. Excess production of sebum—the oil that keeps if SEYSARA is safe and effective for use for longer than 12 weeks. our skin from drying out—can cause the dead skin cells to stick SEYSARA should not be used in children under 9 years of age, or if you together and get trapped inside the pore. 1 are pregnant or breastfeeding. Sometimes the bacteria that live naturally on our skin, C. acnes, also get inside the pore, where they can multiply quickly. With WHAT IS MODERATE TO SEVERE ACNE? bacteria inside, the pore becomes infl amed (red and swollen). If the acne goes deep into the skin, an acne cyst or nodule appears.4 Acne is a common skin condition involving blockage and/or infl ammation of hair follicles and their associated gland. Depending on the severity, acne is generally categorized as mild, moderate, or severe.
    [Show full text]
  • Hirsutism and Polycystic Ovary Syndrome (PCOS)
    Hirsutism and Polycystic Ovary Syndrome (PCOS) A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications Committee. No portion herein may be reproduced in any form without written permission. This booklet is in no way intended to replace, dictate or fully define evaluation and treatment by a qualified physician. It is intended solely as an aid for patients seeking general information on issues in reproductive medicine. Copyright © 2016 by the American Society for Reproductive Medicine AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Hirsutism and Polycystic Ovary Syndrome (PCOS) A Guide for Patients Revised 2016 A glossary of italicized words is located at the end of this booklet. INTRODUCTION Hirsutism is the excessive growth of facial or body hair on women. Hirsutism can be seen as coarse, dark hair that may appear on the face, chest, abdomen, back, upper arms, or upper legs. Hirsutism is a symptom of medical disorders associated with the hormones called androgens. Polycystic ovary syndrome (PCOS), in which the ovaries produce excessive amounts of androgens, is the most common cause of hirsutism and may affect up to 10% of women. Hirsutism is very common and often improves with medical management. Prompt medical attention is important because delaying treatment makes the treatment more difficult and may have long-term health consequences. OVERVIEW OF NORMAL HAIR GROWTH Understanding the process of normal hair growth will help you understand hirsutism. Each hair grows from a follicle deep in your skin. As long as these follicles are not completely destroyed, hair will continue to grow even if the shaft, which is the part of the hair that appears above the skin, is plucked or removed.
    [Show full text]
  • Hair and Nail Disorders
    Hair and Nail Disorders E.J. Mayeaux, Jr., M.D., FAAFP Professor of Family Medicine Professor of Obstetrics/Gynecology Louisiana State University Health Sciences Center Shreveport, LA Hair Classification • Terminal (large) hairs – Found on the head and beard – Larger diameters and roots that extend into sub q fat LSUCourtesy Health of SciencesDr. E.J. Mayeaux, Center Jr., – M.D.USA Hair Classification • Vellus hairs are smaller in length and diameter and have less pigment • Intermediate hairs have mixed characteristics CourtesyLSU Health of E.J. Sciences Mayeaux, Jr.,Center M.D. – USA Life cycle of a hair • Hair grows at 0.35 mm/day • Cycle is typically as follows: – Anagen phase (active growth) - 3 years – Catagen (transitional) - 2-3 weeks – Telogen (preshedding or rest) about 3 Mon. • > 85% of hairs of the scalp are in Anagen – Lose 75 – 100 hairs a day • Each hair follicle’s cycle is usually asynchronous with others around it LSU Health Sciences Center – USA Alopecia Definition • Defined as partial or complete loss of hair from where it would normally grow • Can be total, diffuse, patchy, or localized Courtesy of E.J. Mayeaux, Jr., M.D. CourtesyLSU of Healththe Color Sciences Atlas of Family Center Medicine – USA Classification of Alopecia Scarring Nonscarring Neoplastic Medications Nevoid Congenital Injury such as burns Infectious Systemic illnesses Genetic (male pattern) (LE) Toxic (arsenic) Congenital Nutritional Traumatic Endocrine Immunologic PhysiologicLSU Health Sciences Center – USA General Evaluation of Hair Loss • Hx is
    [Show full text]
  • Avoid Systemic Antifungals for Chronic Paronychia
    32 Skin Disorders FAMILY P RACTICE N EWS • October 1, 2006 Avoid Systemic Antifungals for Chronic Paronychia BY SHERRY BOSCHERT not,” said Dr. Tosti, professor of derma- causing inflammation in the nail matrix. ondary problem, not the primary inflam- San Francisco Bureau tology at the University of Bologna, Italy. Yeast and bacteria also may penetrate the mation, Dr. Tosti said. Instead, it starts with loss of the cuticle proximal nail fold, leading to secondary Chronic paronychia should be managed W INNIPEG, MAN. — Chronic parony- due to trauma or other causes, followed by colonization that may produce self-limit- like contact dermatitis is treated, with chia is a variety of contact dermatitis that irritation, immediate or delayed allergic re- ed episodes of painful acute inflammation hand protection and topical steroids, she affects the proximal nail fold, so treating it action, or immediate hypersensitivity to with pus. A green discoloration of the nail advised. For patients with secondary can- with systemic antifungals is not useful, Dr. food ingredients handled by the patient. develops with colonization by Pseudomonas dida colonization, recommend a high-po- Antonella Tosti said at the annual confer- Chronic paronychia is a common occupa- aeruginosa. tency topical steroid at bedtime and a top- ence of the Canadian Dermatology Asso- tional problem among food workers, she That’s why clinicians may be able to cul- ical antifungal in the morning. “I may use ciation. said. ture bacteria or yeast, but treating with systemic steroids in severe cases” to pro- “Most people still believe that chronic With the cuticle gone, environmental systemic antifungals will not cure the pa- vide fast relief of inflammation and pain, paronychia is a candida infection.
    [Show full text]
  • Consensus Recommendations from the American Acne
    Drug Therapy Topics Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care James Q. Del Rosso, DO; Diane Thiboutot, MD; Richard Gallo, MD; Guy Webster, MD; Emil Tanghetti, MD; Lawrence F. Eichenfield, MD; Linda Stein-Gold, MD; Diane Berson, MD; Andrea Zaenglein, MD Rosacea is a common clinical diagnosis that appear to correlate with the manifestation of encompasses a variety of presentations, predomi- rosacea have been the focus of multiple research nantly involving the centrofacial skin. Reported studies, with outcomes providing a better under- to present most commonly in adults of Northern standing of why some individuals are affected and European heritage with fair skin, rosacea can how their visible signs and symptoms develop. A affect males and females of all ethnicities and better appreciation of the pathophysiologic mech- skin types. Pathophysiologic mechanisms that anisms and inflammatory pathways of rosacea Dr. Del Rosso is from Touro University College of Osteopathic Medicine, Henderson, Nevada, and Las Vegas Skin and Cancer Clinics/ West Dermatology Group, Las Vegas and Henderson. Dr. Thiboutot is from Penn State University Medical Center, Hershey. Dr. Gallo is from the University of California, San Diego. Dr. Webster is from Jefferson Medical College, Philadelphia, Pennsylvania. Dr. Tanghetti is from the Center for Dermatology and Laser Surgery, Sacramento. Dr. Eichenfield is from Rady Children’s Hospital, San Diego, California, and the University of California, San Diego School of Medicine. Dr. Stein-Gold is from Henry Ford Hospital, Detroit, Michigan. Dr. Berson is from Weill Cornell Medical College and New York-Presbyterian Hospital, New York, New York.
    [Show full text]
  • Trachyonychia Associated with Alopecia Areata and Secondary Onychomycosis
    TRACHYONYCHIA ASSOCIATED WITH ALOPECIA AREATA AND SECONDARY ONYCHOMYCOSIS Jose L. Anggowarsito Renate T. Kandou Department of Dermatovenereology Medical Faculty of Sam Ratulangi University Prof. Dr. R. D. Kandou Hospital Manado Email: [email protected] Abstract: Trachyonychia is an idiopathic nail inflammatory disorder that causes nail matrix keratinization abnormality, often found in children, and associated with alopecia areata, psoriasis, atopic dermatitis, or nail lichen planus. Trachyonychia could be a manifestation of associated pleomorphic or idiopathic disorders; therefore, it may occur without skin or other systemic disorders. There is no specific diagnostic criteria for tracyonychia. A biopsy is needed to determine the definite pathologic diagnosis for nail matrix disorder; albeit, in a trachyonychia case it is not entirely necessary. Trachyonychia assessment is often unsatisfactory and its management is focused primarily on the underlying disease. We reported an 8-year-old girl with twenty dystrophic nails associated with alopecia areata. Cultures of nail base scrapings were performed two times and the final impression was trichophyton rubrum. Conclusion: Based on the clinical examination and all the tests performed the diagnosis of this case was trachyonychia with twenty dystrophic nails associated with alopecia areata and secondary onychomycosis.The majority of trachyonychia cases undergo spontaneous improvement; therefore, a specific therapy seems unnecessary. Onychomycosis is often difficult to be treated. Eradication of the fungi is not always followed by nail restructure, especially if there has been dystrophy before the infection. Keywords: trachyonychia, alopecia areata, onychomycosis. Abstrak: Trakionikia adalah inflamasi kuku idiopatik yang menyebabkan gangguan keratinisasi matriks kuku, sering terjadi pada anak, dan terkait dengan alopesia areata, psoriasis, dermatitis atopik atau lichen planus kuku.
    [Show full text]